Joshua Cohen
Co-CEO
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer and Director | $686,200 | $2,719,807 |
| 2024 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer and Director | $686,200 | $6,496,255 |
| 2023 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer and Director | $621,000 | $7,418,169 |
| 2022 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer and Director | $539,275 | $7,178,416 |
| 2021 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer and Director | $417,833 | $1,424,533 |
| 2020 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive officer and Director | $370,000 | $670,500 |
Earnings-call appearances
-
Amylyx Pharmaceuticals, Inc. Q1 FY2026 Earnings Call2026-05-07
Amylyx Pharmaceuticals, Inc. (AMLX)
-
Amylyx Pharmaceuticals, Inc. Q3 FY2025 Earnings Call2025-11-06
Amylyx Pharmaceuticals, Inc. (AMLX)
-
Amylyx Pharmaceuticals, Inc. Q2 FY2025 Earnings Call2025-08-07
Amylyx Pharmaceuticals, Inc. (AMLX)
-
Nutex Health Inc. Q1 FY2025 Earnings Call2025-05-13
Nutex Health Inc. (NUTX)
-
Amylyx Pharmaceuticals, Inc. Q4 FY2024 Earnings Call2025-03-04
Amylyx Pharmaceuticals, Inc. (AMLX)
-
Amylyx Pharmaceuticals, Inc. Q3 FY2024 Earnings Call2024-11-07
Amylyx Pharmaceuticals, Inc. (AMLX)
-
Amylyx Pharmaceuticals, Inc. Q2 FY2024 Earnings Call2024-08-08
Amylyx Pharmaceuticals, Inc. (AMLX)
-
Amylyx Pharmaceuticals, Inc. Q2 FY2023 Earnings Call2023-08-10
Amylyx Pharmaceuticals, Inc. (AMLX)
-
Amylyx Pharmaceuticals, Inc. Q1 FY2023 Earnings Call2023-05-11
Amylyx Pharmaceuticals, Inc. (AMLX)
-
OPAL Fuels Inc. Q3 FY2022 Earnings Call2022-11-01
OPAL Fuels Inc. (OPAL)